Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients

BACKGROUND: The COVID-19 outbreak has led to the rapid development and administration of the COVID-19 vaccines worldwide. Data about the immunogenicity and adverse effects of the vaccine on patients with systemic autoimmune rheumatic diseases (SARDs) is emerging. AIM: To evaluate Pfizer/BioNTech (BN...

Descripción completa

Detalles Bibliográficos
Autores principales: Pri-Paz Basson, Yael, Tayer-Shifman, Oshrat E., Naser, Rawand, Tartakover Matalon, Shelly, Kimhi, Oded, Gepstein, Raz, Halperin, Tamar, Ziv-Baran, Tomer, Ziv, Amit, Parikh, Roma, Kivity, Shaye, Levy, Yair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436715/
https://www.ncbi.nlm.nih.gov/pubmed/36050514
http://dx.doi.org/10.1007/s10067-022-06348-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436715/
https://www.ncbi.nlm.nih.gov/pubmed/36050514
http://dx.doi.org/10.1007/s10067-022-06348-z

Ejemplares similares